IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, will host a Capital Markets Day (CMD) for investors and analysts on Monday 7 April 2025 at 2pm CET / ...

An exotic new approach could shrink kilometer-scale machines into table-top devices.

Human uptake of microplastic particles (MPs) is causing increasing health concerns, and there is mounting pressure to evaluate the associated risks. While MPs can be ingested, breathed in, or drank in ...

IBA (Ion Beam Applications), the world’s leading provider of proton therapy solutions for the treatment of cancer, announces that it has to issue a transparency notification, in accordance with ...

PHUKET: Surplus donations made for the construction of a new cancer treatment building for Vachira Phuket Hospital, the main ...

In the ongoing battle against cancer, the search for more effective treatment measures is relentless. While traditiona ...

Louvain-La-Neuve, Belgium, and Paris, France, 7 February 2025 - Framatome, an international leader in nuclear energy committed to developing products and services for the healthcare industry, and IBA ...

Louvain-La-Neuve, Belgium, and Paris, France, 7 February 2025 - Framatome, an international leader in nuclear energy committed to developi ...

IBA (Ion Beam Applications S.A.) is the world leader in particle accelerator technology. The company is the leading supplier of equipment and services in the field of proton therapy, considered to be ...

Here are 10 recent healthcare industry lawsuits, settlements and legal developments that Becker's has reported on since Jan. 23: ...

PHUKET: People making donations to the construction of the cancer care centre at Vachira Phuket Hospital will not only receive the value of their donation as a tax deduction, but instead will receive ...

Research is progressing on a new form of radiotherapy to treat cancer that has shown promising results, tackling difficult cancers with fewer side-effects.